DONNA SCHARCH: Open Payments
NPI 1043875719 · CENTREVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 42 payments from 26 companies in 2025. Trend: 2023 $968 · 2024 $1,045 · 2025 $1,499
Food & beverage: $1,403Education: $96
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 2 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $127 |
| AstraZeneca Pharmaceuticals LP | 3 | $127 |
| Gilead Sciences, Inc. | 2 | $118 |
| SEAGEN INC. | 1 | $96 |
| Janssen Biotech, Inc. | 2 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Syndax Pharmaceuticals, Inc. | 2 | $62 |
| BeOne Medicines USA, Inc. | 2 | $56 |
Products named: Epkinly, OPDIVO, Trodelvy, RYBREVANT, AYVAKIT, LIBTAYO, KEYTRUDA, SCEMBLIX.
Industry payments across MD — which companies pay providers there.
